Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces Participation in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
August 23, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Completes Enrollment in SCAN Clinical Study

REDWOOD CITY, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
August 13, 2018 16:00 ET | Source: Avinger, Inc.

Avinger Announces Second Quarter 2018 Financial Results

REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the...
August 06, 2018 10:30 ET | Source: Avinger, Inc.

Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018

REDWOOD CITY, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), will announce its second...
July 12, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces Pricing of $3.55 Million Registered Direct Offering

REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
July 10, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer

REDWOOD CITY, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the...
June 26, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US

REDWOOD CITY, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that several...
June 21, 2018 08:30 ET | Source: Avinger, Inc.

Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018

REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Ocelot...
June 14, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound

REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the initiation...
June 13, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Appoints Mark Weinswig as Chief Financial Officer

REDWOOD CITY, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD),...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right